Advertisement

Topics

BioGenesis InvestmentGroup, LLC Company Profile

22:29 EDT 18th June 2018 | BioPortfolio

BioGenesis Investment Group, LLC was originally formed to purchase technology and technology options and to develop these technologies through early development stages.Recently, BioGenesis Investment Group assisted with the transfer of a technology license from Mayo Clinic to Corus Pharma in Seattle, Washington.In 2001, BioGenesis Investment Group developed a technology valuation model for the biotech industry, which took into account the unique valuation nature of drugs in their development phase. Upon making this model public with the Nature Biotechnology Magazine article last September, the Red Herring Magazine article in March, 2002, and the various newspaper articles over the past few months, we received an overwhelming response from the Life Sciences and Finance industries.

Location

721 Lochsa St.
Suite 22
Post Falls
Idaho
83854
United States of America

Contact

Phone: 208-262-2062
Fax: 208-262-2063
Email: jozretich@bizjournals.com


News Articles [21 Associated News Articles listed on BioPortfolio]

Platelet BioGenesis licenses induced pluripotent stem cells from iPS Academia Japan

Platelet Biogenesis, a pioneer in the production of functional human platelets (PLTs+) from stem cells, has licensed patents related to induced pluripotent stem cells (iPS cells) from iPS Academia Jap...

Insights into the biogenesis, function, and regulation of ADP-ribosylation

The RNA-binding protein Hfq is important for ribosome biogenesis and affects translation fidelity

Ribosome biogenesis is a complex process involving multiple factors. Here, we show that the widely conserved RNA chaperone Hfq, which can regulate sRNA-mRNA basepairing, plays a critical role in rRNA ...

Structural basis of the Cope rearrangement and cyclization in hapalindole biogenesis

Corrigendum: Ribosome biogenesis in cancer: new players and therapeutic avenues

Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma

Epigenetic modifiers promote mitochondrial biogenesis and oxidative metabolism leading to enhanced differentiation of neuroprogenitor cells

Platelet BioGenesis Licenses Induced Pluripotent Stem Cell Technology from iPS Academia Japan

Agreement gives groundbreaking human platelet company access to crucial technologies as it advances its program to manufacture human platelets at scale Platelet BioGene...

Drugs and Medications [0 Results]

None

PubMed Articles [160 Associated PubMed Articles listed on BioPortfolio]

Novel retinal findings in peroxisomal biogenesis disorders.

Peroxisomal biogenesis disorders are caused by disruption of long chain fatty acid metabolism due to mutations in PEX genes. Individuals with these disorders often have vision loss due to optic atroph...

Brr6 and Brl1 locate to nuclear pore complex assembly sites to promote their biogenesis.

The paralogous Brr6 and Brl1 are conserved integral membrane proteins of the nuclear envelope (NE) with an unclear role in nuclear pore complex (NPC) biogenesis. Here, we analyzed double-degron mutant...

2-Methoxyestradiol Affects Mitochondrial Biogenesis Pathway and Succinate Dehydrogenase Complex Flavoprotein Subunit A in Osteosarcoma Cancer Cells.

Dysregulation of mitochondrial pathways is implicated in several diseases, including cancer. Notably, mitochondrial respiration and mitochondrial biogenesis are favored in some invasive cancer cells, ...

Diverse Regulators of Human Ribosome Biogenesis Discovered by Changes in Nucleolar Number.

Ribosome biogenesis is a highly regulated, essential cellular process. Although studies in yeast have established some of the biological principles of ribosome biogenesis, many of the intricacies of i...

Inactivation of glycogen synthase kinase 3β (GSK-3β) enhances mitochondrial biogenesis during myogenesis.

Mitochondrial biogenesis is crucial for myogenic differentiation and regeneration of skeletal muscle tissue and is tightly controlled by the peroxisome proliferator-activated receptor-γ co-activator ...

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

The Production of Reactive Oxygen Species in Response to Glutathione Supplementation and Acute Exercise

Objectives: The research focus of the study is the production of reactive oxygen species (ROS) in patients with type 2 diabetes (T2D) in response to glutathione (GSH) supplementation and i...

"TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM

This study is designed to look at the effect of Pioglitazone treatment on the body's ability to burn food in order to produce energy.

Nicotinamide Riboside and Mitochondrial Biogenesis

Mitochondria are important parts of the cell that are responsible for producing energy. The amount of energy they produce depends on how much energy the body needs to function and this ene...

Vitro Study of Tigecycline to Treat Chronic Myeloid Leukemia

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm companies with the BCR-ABL fusion gene encoded by the Philadelphia (Ph) chromosome. The BCR-ABL fusion protein(the formation...

Risk Factors for Early Remodelling in Severe Asthma in Children

- Background: Asthma is a frequent disease characterized by bronchial hyperresponsiveness, inflammation and remodeling. Consistent epidemiological data indicate that outcome of ...

Companies [5 Associated Companies listed on BioPortfolio]

BioGenesis InvestmentGroup, LLC

BioGenesis Investment Group, LLC was originally formed to purchase technology and technology options and to develop these technologies through early development stages.Recently, BioGenesis Investment ...

Biogenesis Ltd

Biogenesis is a recognized leader in the supply of monoclonal and polyclonal antibodies and custom manufacturing services to IVD manufacturers, pharmaceutical companies and life science researchers ar...

Platelet BioGenesis

Platelet BioGenesis is a venture-backed, development stage biotech company creating designer platelets (PLTs+™) as a new class of therapeutics. Platelet BioGenesis has develo...

Biogenesis

Antibodies, Antigens, and other Immunoassy ReagentsContract manufacture of monoclonals, polyclonals, peptides.

MorphoSys AG

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next ge...

More Information about "BioGenesis InvestmentGroup, LLC" on BioPortfolio

We have published hundreds of BioGenesis InvestmentGroup, LLC news stories on BioPortfolio along with dozens of BioGenesis InvestmentGroup, LLC Clinical Trials and PubMed Articles about BioGenesis InvestmentGroup, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioGenesis InvestmentGroup, LLC Companies in our database. You can also find out about relevant BioGenesis InvestmentGroup, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record